References
- Syn N, Wang L, Sethi G, Thiery JP, Goh BC. Exosome-Mediated Metastasis: From Epithelial-Mesenchymal Transition to Escape from Immunosurveillance. Trends Pharmacol Sci 2016; 37(7):606-17; PMID:27157716; http://dx.doi.org/10.1016/j.tips.2016.04.006
- Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brügger B, Simons M. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008; 319(5867):1244-7; PMID:18309083; http://dx.doi.org/10.1126/science.1153124
- Hurley JH. ESCRTs are everywhere. EMBO J 2015; 34(19):2398-407; PMID: 26311197; http://dx.doi.org/10.15252/embj.201592484
- Friand V, David G, Zimmermann P. Syntenin and syndecan in the biogenesis of exosomes. Biol Cell 2015; 107(10):331-41; PMID:26032692; http://dx.doi.org/10.1111/boc.201500010
- Stoorvogel W. Resolving sorting mechanisms into exosomes. Cell Res 2015; 25(5):531-2; PMID:25828531; http://dx.doi.org/10.1038/cr.2015.39
- Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012; 14(7):677-85; PMID:22660413; http://dx.doi.org/10.1038/ncb2502
- Ghossoub R, Lembo F, Rubio A, Gaillard CB, Bouchet J, Vitale N, Slavík J, Machala M, Zimmermann P. Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat Commun 2014; 5:3477; PMID:24637612; http://dx.doi.org/10.1038/ncomms4477
- Roucourt B, Meeussen S, Bao J, Zimmermann P, David G. Heparanase activates the syndecan-syntenin-ALIX exosome pathway. Cell Res 2015; 25(4):412-28; PMID:25732677; http://dx.doi.org/10.1038/cr.2015.29
- Thompson CA, Purushothaman A, Ramani VC, Vlodavsky I, Sanderson RD. Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J Biol Chem 2013; 288(14):10093-9; PMID:23430739; http://dx.doi.org/10.1074/jbc.C112.444562
- Ramani VC, Purushothaman A, Stewart MD, Thompson CA, Vlodavsky I, Au JL, Sanderson RD. The heparanase/syndecan-1 axis in cancer: mechanisms and therapies. FEBS J 2013; 280(10):2294-306; PMID:23374281; http://dx.doi.org/10.1111/febs.12168
- Kegelman TP, Das SK, Emdad L, Hu B, Menezes ME, Bhoopathi P, Wang XY, Pellecchia M, Sarkar D, Fisher PB. Syntenin Targeting tumor invasion: the roles of MDA-9/Syntenin. Expert Opin Ther Targets 2014; 19(1):97-112; http://dx.doi.org/10.1517/14728222.2014.959495
- Kashyap R, Roucourt B, Lembo F, Fares J, Carcavilla AM, Restouin A, Zimmermann P, Ghossoub R. Syntenin controls migration, growth, proliferation, and cell cycle progression in cancer cells. Front Pharmacol 2015; 6:241; PMID:26539120; http://dx.doi.org/10.3389/fphar.2015.00241
- Zimmermann P, Zhang Z, Degeest G, Mortier E, Leenaerts I, Coomans C, Schulz J, N'Kuli F, Courtoy PJ, David G. Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6. Dev Cell.2005 Sep;9(3):377-88. Erratum in: Dev Cell 2005; 9(5):721. PubMed PMID: 16139226.
- Christianson HC, Svensson KJ, van Kuppevelt TH, Li JP, Belting M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. PNAS 2013; 110(43):17380-5; PMID:24101524; http://dx.doi.org/10.1073/pnas.1304266110